Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Anifera to conduct additional bovine mastitis studies
Mastitis costs the global dairy industry an estimated 32 billion USD a year.
The firm is developing compounds that can improve the efficacy of antibiotics.

Animal health firm Anifera has announced plans to conduct additional studies to explore the impact and effectiveness of adjunct therapy in bovine mastitis.

Bovine mastitis is a common disease of dairy cattle that causes inflammation of the udder tissue. The condition is considered to be the most common cause of economic loss for cattle farmers worldwide, owing to reduced milk yield and lower milk quality.

In a press release, Anifera states the new studies will 'build on promising data in bovine mastitis' and have been made possible following 'substantial investment' by Stonehaven Incubate – one of Anifera's co-founders. 

The company is developing compounds that can improve the efficacy of antibiotics, with the ultimate aim of reducing their use in animals. Anifera’s small molecule compounds seek to potentiate the effects of the antibiotic through a unique mechanism of action. 

“We have seen very encouraging results in early studies focused on bovine mastitis, utilising our lead compound as an adjunct therapy to a commercial intramammary antibiotic,” commented Dr Gwynneth Thomas, CEO of Anifera. 

“We look forward to moving ahead with additional development work aimed at further exploring improvements in the efficacy of existing antibiotics when used in combination with our compound, helping to advance sustainability in animal health.”

According to figures published by Anifera, mastitis costs the global dairy industry an estimated 32 billion USD a year. With increasing concerns about restrictions on the use of antibiotics in farm animals, the firm hopes its approach “could help improve health and productivity for dairy farmers worldwide.” 

“Anifera has the potential to pioneer new ways of treating bovine mastitis, offering immediate financial and welfare benefits to dairy farmers,” said Jarne Elleholm, CEO of Stonehaven Incubate. 

“We are committed to helping Anifera advance these important studies and drive innovation to improve the efficacy of antibiotics. We share their goal of ultimately reducing the usage of antibiotics in disease states across animal health where they are the first line of treatment.” 

Become a member or log in to add this story to your CPD history

Practices urged to audit neutering data

News Story 1
 RCVS Knowledge has called on vet practices to audit their post-operative neutering outcomes.

It follows the release of the 2024 NASAN benchmarking report, which collates data from neutering procedures performed on dogs, cats and rabbits.

The benchmarking report enables practices in the UK and Ireland to compare their post-operative outcomes to the national average. This includes the rate of patients lost to follow-up, which in 2024 increased to 23 per cent.

Anyone from the practice can submit the data using a free template. The deadline for next report is February 2026.

Visit the RCVS Knowledge website to complete an audit. 

Click here for more...
News Shorts
RCVS pays tribute to well-loved equine vet

The RCVS and the Riding Establishments Subcommittee has paid tribute to well-loved veterinary surgeon and riding establishment inspector, Rebecca Hamilton-Fletcher MRCVS.

Linda Belton MRCVS, RCVS President, said: "I, along with my colleagues on the RESC, RCVS Council, RCVS Standards Committee, as well as RCVS staff, was very saddened to hear of the sudden death of Rebecca, or Becca as we knew her, last week.

"She was a true advocate for equine welfare and in her many years on the RESC worked to continually improve the quality and consistency of riding establishment inspections, all in the interests of enhanced horse welfare and rider safety."